UK Responsible Person (UKRP) Guide for Medical Devices & IVDs
Overview of UK Medical Device Regulation
Following the UK’s departure from the European Union, the regulatory framework governing medical devices and In Vitro Diagnostic (IVD) devices in Great Britain (England, Scotland, and Wales) operates under the UK Medical Devices Regulations 2002 (UK MDR 2002, as amended).
Under these regulations, any medical device or IVD manufacturer located outside the United Kingdom must designate a UK Responsible Person (UKRP) to place products on the Great Britain market. The UKRP assumes legal responsibility for registering products with the Medicines and Healthcare products Regulatory Agency (MHRA) and serving as the primary liaison between the manufacturer and UK regulatory authorities.
Maintaining compliance requires non-UK manufacturers to pair their UKRP representation with a robust ISO 13485 QMS implementation to ensure technical documentation and post-market surveillance systems satisfy MHRA standards.
Get In Touch with Our UKRP Regulatory Experts
What Is a UK Responsible Person (UKRP)?
A UK Responsible Person is a legal entity physically established in the United Kingdom that acts on behalf of an overseas manufacturer to fulfill statutory obligations under UK MDR 2002.
Functionally, a UKRP is the UK counterpart to the European Union’s Authorized Representative (EC REP). However, unlike standard commercial distributors, a UKRP carries legal regulatory liabilities. The representation must be formalized through a legally binding mandate agreement executed between the non-UK manufacturer and the UKRP.
Manufacturers transitioning from European operations can evaluate how their UKRP structure aligns with CE Marking for EU MDR compliance to eliminate dual-market friction.
Why Appointing a UKRP Is Mandatory
Foreign manufacturers cannot register devices directly on the MHRA Device Online Registration System (DORS) without a physical presence in the UK. Appointing a UK Responsible Person is mandatory to fulfill critical legal prerequisites:
MHRA Database Registration: The UKRP must submit and maintain device listings on the MHRA DORS portal prior to commercial distribution.
Labeling Compliance: The name and address of the UKRP must appear on product labeling, outer packaging, or Instructions for Use (IFU) accompanying devices distributed in Great Britain.
Conformity Assessments: The UKRP verifies that the manufacturer has drawn up valid technical files, applied the appropriate UKCA mark (or accepted CE mark during transition periods), and drafted the Declaration of Conformity (DoC).
Legal Accountable Contact: MHRA holds the UKRP accountable for regulatory communications, post-market inquiries, and safety notices.
Key Statutory Responsibilities of a UKRP
The UKRP acts as an active regulatory compliance safeguard. Key obligations include:
Documentation Verification: Examining technical files, certificates, and Declarations of Conformity to confirm valid conformity assessment procedures.
Technical File Retention: Retaining copies of technical documentation for inspection by the MHRA for a minimum of 10 years (or 15 years for implantable devices).
Vigilance & Incident Reporting: Immediately informing the manufacturer of complaints, adverse events, or suspected incidents reported by UK healthcare professionals, and submitting vigilance reports to the MHRA.
Field Safety Corrective Actions (FSCA): Cooperating with the MHRA and the manufacturer to execute recalls, safety alerts, or corrective actions.
Mandatory Relationship Termination: Under UK MDR regulations, if a non-UK manufacturer fails to maintain compliance or provides false data, the UKRP is legally obligated to terminate the relationship and notify the MHRA.
For products incorporating software, drug components, or specialized delivery systems, technical verification extends to CE marking for drug-device combinations to ensure unified compliance.
Need seamless MHRA device registration?
Consult with Operon Strategist’s UKRP Experts Today to secure your Great Britain market access.
UKRP Appointment & MHRA Registration Timelines
Executing a UKRP agreement and completing device registration follows established regulatory lead times:
| Activity / Compliance Phase | Typical Timeframe | Primary Deliverable |
| UKRP Legal Mandate Agreement | 3 – 4 Working Days | Signed bilateral representation mandate |
| Technical File & Labeling Audit | 5 – 7 Working Days | Gap analysis and labeling verification report |
| MHRA Device Registration (DORS) | 4 – 6 Working Days | Official MHRA registration confirmation & product code |
| Certificate of Free Sale (FSC) | 6 – 8 Working Days | MHRA-issued FSC and Apostille documentation |
Benefits of Partnering with a Qualified UKRP
Selecting an experienced regulatory partner rather than a commercial distributor as your UK Responsible Person ensures distinct strategic advantages:
Protection of Intellectual Property: Commercial distributors may lack regulatory expertise or create conflicts of interest. An independent UKRP protects your confidential technical documentation.
Proactive MHRA Communication: Seamless interaction with MHRA during audits, post-market queries, or regulatory updates.
Regulatory Continuity: Ensures market access remains uninterrupted even if you change local commercial distributors in the UK.
Comprehensive Quality Systems Integration: Expert guidance aligning post-market surveillance (PMS), risk management (ISO 14971), and corrective actions with evolving MHRA standards.
How Operon Strategist Can Help
Operon Strategist provides complete UK Responsible Person (UKRP) services and regulatory representation for medical device and IVD manufacturers entering the Great Britain market:
Legal UKRP Representation: Serving as your official, physically established UK Responsible Person under UK MDR 2002 requirements.
MHRA Registration Management: End-to-end handling of device registration on the MHRA DORS portal, including status updates and fee management.
Technical Documentation Review: Conducting comprehensive technical file audits to verify conformity assessments, labeling, and UKCA / CE declaration validity.
Post-Market Surveillance & Vigilance: Managing incident reporting, customer complaints, and liaison with the MHRA during Field Safety Corrective Actions (FSCAs).
Free Sale Certificate (FSC) Processing: Assisting manufacturers in obtaining Certificates of Free Sale and Apostille documentation from the MHRA for international export.
Global Market Synergy: Seamlessly connecting your UK compliance strategy with multi-jurisdictional clearances, including FDA 510(k) submission support in the United States and CDSCO India regulatory registration.
🚀 Expanding your medical device portfolio across global territories?
Connect directly with our compliance strategists.
FAQ's
What is a UK Responsible Person (UKRP)?
A UKRP is a UK-based legal entity representing non-UK medical device manufacturers to ensure MHRA compliance and product registration.
When is appointing a UKRP mandatory?
It is legally required whenever a manufacturer located outside the UK places medical devices or IVDs on the Great Britain market.
Can an importer or distributor act as a UKRP?
Yes, but appointing an independent regulatory partner protects your technical IP and avoids commercial conflicts of interest.
How long does MHRA registration take with a UKRP?
Once technical documentation is verified, MHRA registration via the UKRP typically takes 4 to 6 working days.
What address must appear on medical device labels in Great Britain?
The device label must display the name and UK address of the appointed UK Responsible Person alongside manufacturer details.